Neko Health Expands to the US with New York Office

Neko Health, the health-scanning startup co-founded by Spotify CEO Daniel Ek, has announced its expansion into the US market with the opening of its first American office in New York. Located in the heart of Manhattan’s luxury shopping district, SoHo, at 300 Lafayette Street, the new office is set to bring Neko’s proprietary body-scanning technology and health assessment services to the US market.

Founded by Ek and Hjalmar Nilsonne, who serves as Neko’s CEO, the company has already gained significant traction in the UK and Sweden, with over 25,000 New Yorkers joining a waitlist to experience its services. With a $700 million Series C funding last month, Neko has solidified its position as a leading player in the health-scanning industry.

A Growing Market for Health Scanning

Neko Health is part of a growing trend of health-scanning companies created by tech founders or backed by VCs. Midjourney, an AI lab known for its AI image and video creation model, is also developing a body scanner to integrate into a spa experience, set to open in San Francisco in 2027. Tony Robbins and Peter Diamandis have a longevity company called Fountain Life that offers scans and health assessments, while Function Health, co-founded by wellness podcaster Dr. Mark Hyman, provides blood testing and has added body scans after acquiring the startup Ezra.

Function Health recently took on a $450 million loan from General Catalyst’s Customer Value Fund, which will be repaid via profit-sharing arrangements. This influx of funding highlights the growing interest in health-scanning technology and its potential to revolutionize the healthcare industry.

Neko’s Proprietary Technology

Neko’s body-scanning technology uses a combination of proprietary software, bloodwork, and data from fitness devices to assess a person’s health. This comprehensive approach provides individuals with a detailed understanding of their physical and mental well-being, allowing them to make informed decisions about their health.

The company’s technology has already been adopted by over 100,000 people worldwide, with a significant portion of those users being from the UK and Sweden. With its expansion into the US market, Neko Health is poised to bring its innovative health-scanning technology to a wider audience.

A Bright Future for Neko Health

Neko Health’s expansion into the US market is a significant milestone for the company, marking a new chapter in its journey to revolutionize the healthcare industry. With its cutting-edge technology and growing presence in the market, Neko is well-positioned to make a lasting impact on the lives of individuals and communities worldwide.

The company’s commitment to innovation, customer satisfaction, and data-driven decision-making will undoubtedly drive its continued growth and success in the years to come.